ConductScience.org, home

Paper42101807

Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach.

Singh L and 3 others. Pharmacol Rep, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach. Papers, record 42101807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42101807

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach.
PubMed
Journal
Pharmacol Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-06-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh LLovedeephttps://orcid.org/0000-0002-2903-4293
2Singh AAnishhttps://orcid.org/0000-0002-8547-2263
3Kattna AAyush
4Dalal DDikshahttps://orcid.org/0000-0003-1707-6135

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140599626The burden of acute kidney disease: an epidemiological review and importance of follow-up care.Clin Kidney J2025https://conductscience.org/library/papers/40599626PubMed
237165615Acute kidney disease: an overview of the epidemiology, pathophysiology, and management.Kidney Res Clin Pract2023https://conductscience.org/library/papers/37165615PubMed
338365413An update on the global disparities in kidney disease burden and care across world countries and regions.Lancet Glob Health2024https://conductscience.org/library/papers/38365413PubMed
439199307Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis.Biomolecules2024https://conductscience.org/library/papers/39199307PubMed
541150801The Pathogenesis of Chronic Kidney Disease (CKD) and the Preventive and Therapeutic Effects of Natural Products.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150801PubMed
632082479Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers.Oxid Med Cell Longev2020https://conductscience.org/library/papers/32082479PubMed
737569752Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies.Int J Mol Sci2023https://conductscience.org/library/papers/37569752PubMed
830248418Nrf2 activator for the treatment of kidney diseases.Toxicol Appl Pharmacol2018https://conductscience.org/library/papers/30248418PubMed
921189948Renal fibrosis.Korean J Pediatr2010https://conductscience.org/library/papers/21189948PubMed
1016408108Renal fibrosis: new insights into the pathogenesis and therapeutics.Kidney Int2006https://conductscience.org/library/papers/16408108PubMed
1129740333Flavonoids in Kidney Health and Disease.Front Physiol2018https://conductscience.org/library/papers/29740333PubMed
1226361743Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.Brain Res Bull2015https://conductscience.org/library/papers/26361743PubMed
1339165588Recent insights into luteolin and its biological and pharmacological activities.EXCLI J2024https://conductscience.org/library/papers/39165588PubMed
1436358895Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries.Biomolecules2022https://conductscience.org/library/papers/36358895PubMed
1537713990Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies.Biomed Pharmacother2023https://conductscience.org/library/papers/37713990PubMed
1639100967Luteolin Alleviates Diabetic Nephropathy Fibrosis Involving AMPK/NLRP3/TGF-β Pathway.Diabetes Metab Syndr Obes2024https://conductscience.org/library/papers/39100967PubMed
1739479625Luteolin ameliorates hyperuricemic nephropathy by activating urate excretion and Nrf2/HO-1/NQO1 antioxidant pathways in mice.Food Sci Nutr2024https://conductscience.org/library/papers/39479625PubMed
1833827303Luteolin attenuates doxorubicin-induced derangements of liver and kidney by reducing oxidative and inflammatory stress to suppress apoptosis.Hum Exp Toxicol2021https://conductscience.org/library/papers/33827303PubMed
1931091348Protective role of luteolin against bisphenol A-induced renal toxicity through suppressing oxidative stress, inflammation, and upregulating Nrf2/ARE/ HO-1 pathway.IUBMB Life2019https://conductscience.org/library/papers/31091348PubMed
2025587925Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation.Nat Prod Res2015https://conductscience.org/library/papers/25587925PubMed

See all 76 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42939744Edaravone for Potential Mitigation of Oxidative Stress and Inflammation in Kidney Disease.Biomolecules2026https://conductscience.org/library/papers/42939744PubMed
42824465Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways.Biomater Biosyst2026https://conductscience.org/library/papers/42824465PubMed
42769453Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway.Front Pharmacol2026https://conductscience.org/library/papers/42769453PubMed
42712548Effects and potential mechanisms of astragaloside IV in animal models of renal fibrosis: a systematic review and meta-analysis.Front Pharmacol2026https://conductscience.org/library/papers/42712548PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42101807

GET https://conductscience.org/api/papers/v1/42101807/references?page=2